Tirzepatide in Canada: A Researcher’s Buying Guide
Tirzepatide is the most-searched research peptide on the internet right now — and one of the most misunderstood. It is a dual GIP/GLP-1 receptor agonist, studied in laboratory settings for its effect on two incretin pathways at once rather than one. For Canadian researchers the practical questions are the same as ever: where to source it domestically, what to verify before ordering, and how it compares to the other metabolic compounds it gets grouped with.
Why researchers source Tirzepatide domestically
Research peptides ordered across the border are routinely held or seized at customs, and a lyophilised peptide gains nothing from sitting in a border facility. Sourcing from within Canada removes that exposure entirely: Tirzepatide (10 mg, lyophilised) ships from domestic stock, e-transfer and credit card are both accepted, and orders placed before 3 PM PST dispatch the same day. Free shipping applies over $150.
What to check before you buy
- Purity documentation. A supplier should state the purity figure, not a generic marketing claim. Every Vistara Labs product page lists it.
- Format and reconstitution. Tirzepatide is supplied as a lyophilised powder in a sealed vial and reconstituted with bacteriostatic water for laboratory handling — see our bacteriostatic water explainer if that step is new to you.
- Research-use framing. In Canada these compounds are sold strictly for laboratory research. A legitimate supplier is explicit about that; see our overview of the legal landscape.
Tirzepatide vs Retatrutide vs Semaglutide
Tirzepatide acts on two incretin receptors (GIP and GLP-1); semaglutide acts on one (GLP-1); retatrutide adds a third (glucagon) on top of both. Researchers choosing between them usually want the mechanism differences side by side — we compare retatrutide and tirzepatide here, and the whole incretin family is written up in our GLP-1/2/3 explainer. The broader compound set lives on the Recherche sur la perte de poids et le métabolisme page.
Frequently asked questions
Where can I buy Tirzepatide in Canada?
From domestic research suppliers. Vistara Labs stocks Tirzepatide 10 mg and ships from within Canada — no customs risk, e-transfer and credit card accepted, same-day dispatch before 3 PM PST.
Is Tirzepatide legal in Canada?
It is sold for laboratory research use only, the same framing as other research peptides. It is not sold for human use, and nothing here is medical advice.
How is Tirzepatide supplied?
As a lyophilised powder in a sealed vial, third-party tested, with the purity figure shown on the product page. It is reconstituted with bacteriostatic water for research handling.
What is the difference between Tirzepatide and Retatrutide?
Tirzepatide is a dual GIP/GLP-1 agonist; retatrutide adds glucagon-receptor activity as a third pathway. The full comparison is here.
All products discussed are for laboratory research use only and are not for human use. Nothing on this page is medical advice, and no statement about any compound is a claim of therapeutic benefit.
References
Tirzepatide has one of the largest human trial programmes of any compound in this catalogue, including multiple phase 3 trials.
- Tirzepatide Once Weekly for the Treatment of ObesityRandomised phase 3 trial (SURMOUNT-1); 2,539 adults with overweight or obesity without diabetes, 72 weeks.
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialRandomised phase 3 withdrawal trial (SURMOUNT-4); 670 participants randomised after a 36-week open-label phase.
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityRandomised phase 3 trials in adults with obesity and moderate-to-severe obstructive sleep apnoea (SURMOUNT-OSA).
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityRandomised phase 3 trial (SUMMIT); 731 patients with obesity-related heart failure with preserved ejection fraction.
- Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysisSystematic review and meta-analysis; 22 trials, 29,023 participants.
Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.
